You Searched For "gilead stock" and got 20 results
Sort By:
2 mins read
Wall Street says buy stocks that pay dividends with $6 trillion of cash ready to be deployed
"We see more opportunities within equities for investors searching for yield," Bank of America's Sa…
Matthew Fox
2 mins read
Alexandria Ocasio-Cortez says it's 'absolutely wild' that senators can trade stocks after Rand Paul discloses controversial Gilead purchase
The politician said members of Congress should not be able to trade stocks after Rand Paul disclose…
Harry Robertson
2 mins read
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
2 mins read
Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion
Gilead expects the deal to immediately bolster its revenue growth, and to be neutral to accretive t…
Matthew Fox
2 mins read
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
2 mins read
Gilead surges 17% on report that drug shows effectiveness against COVID-19
In a Chicago hospital, all patients with Covid-19 treated with Gilead's Remdesivir were discharged …
Carmen Reinicke
2 mins read
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
2 mins read
2 biotech stocks plummet more than 25% after the FDA rejects their drug applications
Filgotinib is expected to deliver billions in sales for Gilead, so the delay is a disappointment to…
Matthew Fox
2 mins read
Dow surges 500 points on optimism around US economic reopening plan
Positive results reported from Gilead's coronavirus treatment trials offered new optimism around an…
Ben Winck
2 mins read
Pharmaceutical giants have added $51 billion to their market value in 2020 as they scramble to develop a coronavirus vaccine
Gilead Sciences was the frontrunner among 6 pharma companies helped by its trials of the antiviral …
Shalini Nagarajan
1 min read
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
2 mins read
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
3 mins read
Global stocks are surging after pharmaceutical giant Gilead said it's making progress on a drug to treat coronavirus
"I agree that most of the countries are about to see their coronavirus peak, but massive damage has…
Saloni Sardana
2 mins read
Mega-cap tech stocks have gotten so big that the Nasdaq 100 is about to undergo a 'special rebalance' to address overconcentration
There are seven potential winners of the Nasdaq 100 shake up, including Starbucks, Gilead Sciences,…
Matthew Fox
2 mins read
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir
Governments of developed countries will pay $2,340 for a five-day course of the antiviral drug remd…
Andrew Dunn
3 mins read
The US government's supply of remdesivir — the only drug proved to treat the coronavirus — is due to run out at the end of June
The number of US COVID-19 patients requiring remdesivir outnumbers available stocks by two to one, …
Bill Bostock
1 min read
Gilead just made a $4.9 billion bet on cancer-drug maker Forty Seven, whose stock skyrocketed 62%
Best known for its treatments for conditions like HIV and hepatitis C, Foster City, California-base…
Lydia Ramsey
1 min read
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
1 min read
Study results for a leading potential coronavirus treatment were accidentally released by the WHO and then taken down
About 14% of severe coronavirus patients taking the drug remdesivir died compared to 13% who got a …
Andrew Dunn
2 mins read
Noida-based Jubilant inks packs with Gilead to produce, sell remdesivir
The pact allows Jubilant to register, manufacture and sell remdesivir in 127 countries, includin…